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Abstract: Piper guineense is a food and medicinal plant commonly used to treat infectious diseases
in West-African traditional medicine. In a bid to identify new antibacterial compounds due
to bacterial resistance to antibiotics, twelve extracts of P. guineense fruits and leaves, obtained
by sequential extraction, as well as the piperine and piperlongumine commercial compounds
were evaluated for antibacterial activity against human pathogenic bacteria. HPLC-DAD and
UHPLC/Q-TOF MS analysis were conducted to characterize and identify the compounds present in
the extracts with promising antibacterial activity. The extracts, with the exception of the hot water
decoctions and macerations, contained piperamide alkaloids as their main constituents. Piperine,
dihydropiperine, piperylin, dihydropiperylin or piperlonguminine, dihydropiperlonguminine,
wisanine, dihydrowisanine and derivatives of piperine and piperidine were identified in a hexane
extract of the leaf. In addition, some new piperamide alkaloids were identified, such as a piperine
and a piperidine alkaloid derivative and two unknown piperamide alkaloids. To the best of our
knowledge, there are no piperamides reported in the literature with similar UVλ absorption maxima
and masses. A piperamide alkaloid-rich hexane leaf extract recorded the lowest MIC of 19 µg/mL
against Sarcina sp. and gave promising growth inhibitory effects against S. aureus and E. aerogenes as
well, inhibiting the growth of both bacteria with a MIC of 78 µg/mL. Moreover, this is the first report
of the antibacterial activity of P. guineense extracts against Sarcina sp. and E. aerogenes. Marked growth
inhibition was also obtained for chloroform extracts of the leaves and fruits against P. aeruginosa with
a MIC value of 78 µg/mL. Piperine and piperlongumine were active against E. aerogenes, S. aureus,
E. coli, S. enterica, P. mirabilis and B. cereus with MIC values ranging from 39–1250 µg/mL. Notably,
the water extracts, which were almost devoid of piperamide alkaloids, were not active against the
bacterial strains. Our results demonstrate that P. guineense contains antibacterial alkaloids that could
be relevant for the discovery of new natural antibiotics.
Keywords: Piperamides; antibacterial; Piper guineense; piperine; piperlongumine
1. Introduction
Bacterial infections, resulting from bacterial contamination of food and water as well as from
wound and post-operative infections are currently a menace in Sub-Saharan Africa [1]. The continuous
increase in microbial resistance due to the gross misuse of antibiotics has led to a decline in the
effectivity of antibiotic treatments. Consequently, there is a constant need for new antibacterial drugs
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with good efficacy, few and mild adverse effects and low cost. The increasing microbial resistance to
antibiotics has led to the search for new antibacterial agents from medicinal plants [2] and medicinal
plants such as Piper guineense and Xylopia aethiopica, which are used in the treatment of bacterial
infections in West African traditional medicine, could be good sources for these compounds. Based
on numerous pharmacological studies, there is growing interest in medicinal plants as sources of
antibacterial agents and adjuvants [3,4]. It has been established that plant-derived compounds and
plant extracts are potential sources for new antibacterial drugs against multi-drug-resistant (MDR)
pathogens [3,5]. In many African countries, bacterial infections are among the main causes of diseases
that affect the population and they often lead to life-threatening complications and can frequently
result in death. Due to the prevalence of these bacterial infections and lack of adequate modern
health facilities, low income earners in remote communities often practice self-medication, using
herbal formulations for the treatment of bacterial infections. Moreover, a greater number of them seek
medications from traditional medical practitioners (TMP), due to the high cost of treatment associated
with the few modern health facilities [6]. The availability and accessibility of numerous medicinal
plants in Africa has led to the use of plant extracts as herbal remedies for infectious diseases.
Piper guineense Schumach & Thonn, also known as African guinea pepper or African black pepper,
is a medicinal plant that has a wide application in traditional medicine and is therefore of great
ethnobotanical interest [7–9]. It is a perennial climbing vine reaching heights of 20 m. African black
pepper has a pungent aroma and the fruits, leaves and roots are used for the preparation of herbal
remedies for the treatment of infectious diseases [10,11]. In recent studies, P. guineense has been shown
to be one of the most valuable spices with numerous health benefits [12]. In an ethnopharmacological
survey conducted by Ajibesin et al. [13], P. guineense was found to be one of the major medicinal plants
used for the treatment of various sexually transmitted diseases. Phytochemical studies have revealed
that alkaloids, some of which could be novel drug compounds or scaffolds, are the main antimicrobial
compounds present in P. guineense [14–17].
The aim of this study was to screen extracts of various polarities of P. guineense fruits and
leaves and piperine and piperlongumine commercial compounds for antibacterial activity against
significant human pathogenic bacteria including five Gram-negative and three Gram-positive bacteria.
An agar well diffusion and a microdilution method were used for the screenings [18]. Moreover,
selected extracts with promising antibacterial activities were investigated for their phytochemical
composition using HPLC-DAD and UHPLC/Q-TOF MS in search of antibacterial extracts and
compounds. Although P. guineense crude extracts have been previously reported to exhibit antibacterial
properties [19–23], to the best of our knowledge, this is the first report on the antibacterial effects
of P. guineense extracts of various polarities obtained by sequential extraction, supporting its
ethnopharmacological uses. The present study is also the first report on the antibacterial evaluation
of P. guineense extracts against Enterobacter aerogenes and Sarcina sp. Alsoverylittle is known about
the antibacterial activity of the commercial piperamide compounds piperlongumine and piperine
against these pathogenic bacterial strains. Since piperine and its related derivatives and synthetic
piperine analogues are currently paving way as therapeutic agents for multiple human infectious
diseases [24,25], there is a need to screen related piperamides against pathogenic multidrug-resistant
bacteria such as Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus.
2. Results
2.1. Antibacterial Activity
The results for the antibacterial activity of P. guineense extracts of various polarities are shown in
Tables 1 and 2. The bacteria used for the screenings were model human pathogenic bacteria that are of
clinical importance.
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Table 1. Antibacterial effects of extracts of P. guineense, piperine and piperlongumine against Gram-negative bacteria. Results obtained with the agar diffusion method.
Activity index (AI) describes the activity of the extracts and compounds in relation to tetracycline.
Extracts/Antibiotics E. aerogenes AI Tet. E. coli AI Tet. P. aeruginosa AI Tet. S. enterica AI Tet. P. mirabilis AI Tet.
PSMeOH 49.7 ± 0.33 1.10 20.7 ± 0.33 0.42 16.3 ±0.33 0.29 13.3 ± 0.67 0.31 13.7± 0.72 0.34
PSCHCL3 11.3 ± 0.33 0.25 20.3 ± 0.33 0.41 17.7 ±0.33 0.32 18.0 ± 0.0 0.32 11.3 ± 0.33 0.28
PSHex 34.7 ± 0.33 0.76 NA NA NA NA 12.7 ± 0.71 0.23 11.7 ± 0.33 0.29
PSH2O * NA NA NA NA NA NA NA NA NA NA
PSHH2O NA NA NA NA NA NA NA NA NA NA
PSEthanol 30.2 ± 0.17 0.67 19.8 ± 0.24 0.40 NT NT 21.7 ± 0.33 0.39 16.3 ± 0.32 0.40
PLMeOH 29.3 ± 0.33 0.65 11.3 ± 0.33 0.23 15.3 ± 0.33 0.28 12.0 ± 0.00 0.22 11.3 ± 0.31 0.28
PLCHCL3 11.3 ± 0.33 0.25 20.3 ± 0.33 0.41 21.3 ± 0.33 0.38 11.7 ± 0.33 0.21 10.7 ± 0.23 0.26
PLHex 17.8 ± 0.17 0.39 NA NA NA NA NA NA 11.7 ± 0.33 0.29
PLH2O * NA NA NA NA NA NA NA NA NA NA
PLHH2O NA NA NA NA NA NA NA NA NA NA
PLEthanol 25.0 ± 0.00 0.55 16.3 ± 0.33 0.33 NT NT 16.2 ± 0.24 0.29 13.8 ± 0.2 0.34
Piperine 18.7 ± 0.67 0.41 22.3 ± 0.32 0.45 15.7 ± 0.73 0.28 14.7 ± 0.32 0.26 16.0 ± 0.63 0.39
Piperlongumine 12.7 ± 0.65 0.28 20.0 ± 0.33 0.40 13.3 ± 0.32 0.24 11.3 ± 0.33 0.20 NA NA
Rifampicin 38.0 ± 0.00 0.84 40.3 ± 0.34 0.81 45.3 ± 0.33 0.81 39.3 ± 0.33 0.71 34.3 ± 0.33 0.8
Tetracycline 45.3 ± 0.67 1.00 49.7 ± 0.33 1.00 55.7 ± 0.33 1.00 55.7 ± 0.33 1.00 40.7 ± 0.74 1.00
The diameter of the zones of inhibition in mm calculated as the mean of triplicates (n = 3) ± SEM (standard error of mean). PSMeOH, P. guineense fruit methanol extract; PSCHCL3,
P. guineense fruit chloroform extract; PSHex, P. guineense fruit hexane extract; PSH2O *, P. guineense fruit cold water maceration; PSHH2O, P. guineense fruit hot water decoction; PSEthanol,
P. guineense fruit ethanol extract; PLMeOH, P. guineense leaf methanol extract; PLCHCL3, P. guineense leaf chloroform extract; PLHex, P. guineense leaf hexane extract; PLH2O *, P. guineense
leaf cold water maceration; PLHH2O, P. guineense leaf hot water decoction; PLEthanol, P. guineense leaf ethanol extract; AI Tet., activity index in relation to tetracycline; NA, not active and
NT, not tested.
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Table 2. Antibacterial effects of extracts of Piper guineense, piperine and piperlongumine against
Gram-positive bacteria. Results obtained with the agar diffusion method. Activity index (AI) describes
the activity of the extracts and compounds in relation to tetracycline.
Extracts/Antibiotics Sarcina sp. AI Tet. S. aureus AI Tet. B. cereus AI Tet.
PSMeOH 29.83 ± 0.17 0.72 15.7 ± 0.33 0.32 23.7 ± 0.32 0.44
PSCHCL3 31.67 ± 0.33 0.76 17.3 ± 0.67 0.35 15.7 ± 0.33 0.29
PSHex 37.67 ± 0.33 0.90 17.3 ± 0.33 0.35 19.7 ± 0.33 0.36
PSH2O * 10.67 ± 0.33 0.26 NA NA NA NA
PSHH2O 17.67 ± 0.33 0.42 NA NA NA NA
PSEthanol 28.33 ± 0.33 0.68 22.67 ± 0.33 0.46 24.5 ± 0.33 0.45
PLMeOH 26.17 ± 0.17 0.63 14.7 ± 0.33 0.30 29.3 ± 0.33 0.54
PLCHCL3 25.67 ± 0.33 0.62 16.7 ± 0.67 0.34 15.3 ± 0.32 0.28
PLHex 33.67 ± 0.33 0.81 15.0 ± 0.00 0.30 24.7 ± 0.31 0.45
PLH2O * 10.67 ± 0.33 0.26 NA NA NA NA
PLHH2O 14.33 ± 0.33 0.34 NA NA NA NA
PLEthanol 25.17 ± 0.17 0.60 17.5 ± 0.29 0.35 28.2 ± 0.24 0.52
Piperine 27.67 ± 0.33 0.66 18.3 ± 0.33 0.37 12.7 ± 0.33 0.23
Piperlongumine 23.67 ± 0.33 0.57 15.3 ± 0.33 0.31 15.7 ± 0.3 0.29
Rifampicin 39.33 ± 0.33 0.94 48.3 ± 0.33 0.98 50.7 ± 0.33 0.93
Tetracycline 41.67 ± 0.33 1.00 49.3 ± 0.33 1.00 54.3 ± 0.32 1.00
The diameter of the zones of inhibition in mm calculated as the mean of triplicates (n = 3) ± SEM (standard error of
mean). For the key to other abbreviations, see Table 1. PSH2O *, P. guineense fruit cold water maceration and PLH2O
*, P. guineense leaf cold water maceration.
2.1.1. Antibacterial Activity of P. guineense Extracts against Pseudomonas aeruginosa
Themethanol and chloroform extracts of the leaves and fruits of P guineense were effective against
Pseudomonas aeruginosa with inhibition zones ranging from 15.3–21.3 mm (Table 1). In agreement with
our results for the fruits, Eruteya et al. [26], reported that a methanol extract of P. guineense fruits gave
the best growth inhibitory activity against P. aeruginosa. However, in our study, a chloroform leaf
extract gave the largest inhibition zone of 21.3 mm, whereas a methanol leaf extract gave a significantly
smaller IZ of 15.3 mm, which could be due to the higher concentrations of other piperamide alkaloids
relative to piperine in the chloroform extract compared to the methanol extract of the leaves. Moreover,
the minimum inhibitory concentrations (MIC) of the chloroform extracts were 78 µg/mL for both
fruits and leaf, while the MIC of the methanol extracts were 1250 µg/mL for both the fruits and
leaves and these results correlated well with the agar diffusion results for these extracts (Table 3).
Our result demonstrates that chloroform extracts of the leaves of P. guineense containa high variety
and concentration of piperamide alkaloids and other non-polar compounds that may be explored
as antibacterial agents, alone and in combinations with antibiotics, for multidrug-resistant bacteria.
In addition to the extracts, we studied the antibacterial effects of some piperamide alkaloids, such as
piperine, which we have found to be present in high concentrations in P. guineense leaves (Figure 1)
and piperlongumine, which is known in many species of Piper, although we did not find it in the
leaves of P. guineense. Piperine gave moderate activity against P. aeruginosa with an inhibition zone
of 13.3 mm and MIC of 156 µg/mL and thus, may not be the only bioactive compound responsible
for the good growth inhibitory effects of the leaf chloroform extract of P. guineense. Thus, some other
piperamide alkaloids in the leaf extract of P. guineense are suggested to be even more effective and
should be tested alone for their growth inhibitory effects against P. aeruginosa. Piperlongumine was
more effective against P. aeruginosa in terms of the sizes of its inhibition zones of (15.7 mm) but gave a
higher MIC value (312 µg/mL) than piperine. However, it is interesting to note that the hexane and
water extracts of both leaves and fruits of P. guineense were not active against Pseudomonas aeruginosa.
This result might be explained by the absence of piperamide alkaloids in the water extracts. Moreover,
the inactivity of the hexane extracts could possibly be reflected to their smaller quantity of piperamides
when compared to the chloroform extracts. Our results demonstrate that P. guineense could be a source
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of new antibacterial agents or adjuvants that could be relevant for the treatment of infections associated
with Pseudomonas aeruginosa.
Table 3. Minimum inhibitory concentration and minimum bactericidal concentrations (MIC and MBC)
in µg/mL of fruit and leaf extracts of Piper guineense and the alkaloids piperine and piperlongumine.
Plant Extracts and
Antibiotics Sarcina sp. S. aureus B. cereus P. mirabilis E. aerogenes E. coli P. aeruginosa S. enterica
PSMeOH
MIC 39 625 78 1250 39 1250 1250 625
MBC 78 1250 156 2500 78 2500 2500 1250
PSCHCL3
MIC 156 156 625 2500 312 312 78 78
MBC 312 312 1250 NT 625 625 156 156
PSHex
MIC 39 78 625 2500 39 NA NA 2500
MBC 78 156 1250 NT 78 NA NA NT
PSEthanol
MIC 39 78 39 78 78 156 NT 78
MBC 78 156 78 156 156 312 NT 156
PLMeOH
MIC 39 312 78 1250 39 1250 1250 625
MBC 78 625 156 2500 78 2500 2500 1250
PLCHC3
MIC 78 625 625 2500 312 312 78 78
MBC 156 1250 1250 NT 625 625 156 156
PLHex
MIC 19 78 625 1250 78 NA NA NT
MBC 39 156 1250 2500 156 NA NA NT
PLEthanol
MIC 39 78 39 78 78 312 NT 78
MBC 78 156 78 156 156 625 NT 156
Piperine
MIC 19 39 625 78 39 19 156 78
MBC 39 78 1250 156 78 39 312 156
Piperlongumine
MIC 9.7 156 78 NA 156 39 312 625
MBC 19 312 156 NA 312 78 625 1250
Tetracycline
MIC 0.48 0.97 0.48 1.95 0.48 0.48 0.48 0.97
Rifampicin
MIC 0.97 0.97 0.48 0.97 0.48 0.48 0.48 0.48
For the key to other abbreviations, see Table 1. The extracts with marked MIC values are in bold.
2.1.2. Antibacterial Activity of P. guineense Extracts against Bacillus Cereus
Extracts from P. guineense were susceptible to B. cereus with inhibition zones ranging from
15.3–29.3 mm (Table 2). The largest zones of inhibition (29.3 mm and 28.2 mm) were observed
with the methanol and ethanol extracts of the leaves and this result correlated well with the MIC
values for these extracts, which were found to be 78 µg/mL and 39 µg/mL, respectively. The inhibition
zones for the methanol and ethanol extracts of the fruits were 23.7 mm and 24.5 mm, respectively and
the MIC values of these extracts were 78 µg/mL and 39 µg/mL. Based on the result obtained with
this bacterium, it is interesting to note that the leaf extracts were more active than the fruit extracts.
It could be possible that the leaf contains more antibacterial compounds that could inhibit the growth
of this particular bacterium. Moreover, we found that the hexane and chloroform extracts were active
against B. cereus but in contrast the water extracts were not active. This result demonstrates that the
piperamide alkaloids present both in the methanol and ethanol extracts, as well as in the hexane extract
of the leaf (Figure 1) is important for the growth inhibitory effects of these extracts against B. cereus.
Thus, the inactivity of the water extract could be related to the absence of piperamide alkaloids in
this extract.
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Our results could justify the use of P. guineense ethanol extracts asherbal remedy for the treatment
of diarrhoea related to foodborne diseases.
2.1.3. Antibacterial Activity of P. guineense Extracts against Staphylococcus Aureus
P. guineense extracts and pure compounds were active against S. aureus with inhibition zones
ranging from 14.7–22.67 mm. In this study, the largest inhibition zone of 22.67 mm was observed with
an ethanol extract of the fruits, followed by a leaf ethanol extract and chloroform and hexane extracts of
the fruits (Table 2). For the ethanol extract of the fruits, our agar diffusion results correlated well with
the MIC resultof 78 µg/mL (Table 3). However, this same MIC of 78 µg/mL could also be recorded
for the ethanol extract of the leaves as well as the fruit hexane and chloroform extracts, even though
these extracts produced smaller inhibition zones than the leaf ethanol extract. In contrast to the other
extracts we found that the water extracts of both the leaves and fruits showed no inhibition. Thus,
our result suggests that P. guineense should not be used as water extracts for the treatment of bacterial
infections but rather the fruits or leaves should be soaked with alcohol. When compared to the extracts
of P. guineense, we found that the piperamide alkaloids, present in the extracts, were not more growth
inhibitory. Piperine was more active than piperlongumine, giving an inhibition zone of 18.3 mm and a
MIC of 78 µg/mL, compared to 15.3 mm and 156 µg/mL for piperlongumine. This result indicates that
piperine is one of the piperamide alkaloids in the ethanol, methanol, chloroform and hexane extracts
of P. guineense which could be growth inhibitory against S. aureus. Our phytochemical profiling of
the extracts using HPLC-DAD and UHPLC/QTOF-MS shows that P. guineense leaves contain a high
variety of piperamide alkaloid derivatives which could all be critical for the antibacterial effects of
these extracts (Table 4, Figure 2). Our result correlates with the previous report that piperlongumine
has moderate activity against S. aureus [27]. Moreover, in agreement with our results, previous reports
have also shown that the water extracts of P. guineense are usually less effective when compared to the
methanol, ethanol and hexane extracts [23]. Our results on the antibacterial activity of the extracts of
P. guineense against Staphylococcus aureus justify the use of alcohol extracts and soups containing this
plant for the treatment of common foodborne and other infections caused by this bacterium.
2.1.4. Antibacterial Activity of P. guineense Extracts against Sarcina sp.
Sarcina sp. was the most sensitive bacterium to extracts of P. guineense. The methanol, ethanol,
chloroform and hexane extracts of P. guineense showed promising growth inhibitory activity with MIC
values between 19–39 µg/mL and inhibition zones ranging from 25.67–37.67 mm (Table 2). The largest
inhibition zones were observed with hexane fruit and leaf extracts, showing remarkable zones of
inhibition of 37.67 and 33.67 mm, respectively. Accordingly, the hexane leaf extract also gave a low
MIC of 19 µg/mL and was thus as effective as piperine which gave an identical MIC value (Table 3).
The antibacterial activity of the hexane leaf extract and the other effective extracts can be attributed to
the occurrence of piperine and other piperamide alkaloids as the main constituents in these extracts
(Table 4, Figure 1). To the best of our knowledge, this is the first report on the growth inhibitory effects
of P. guineense extracts on Sarcina sp. Sarcina sp. is an anaerobic Gram-positive bacterium belonging to
the family Clostridiaceae [28]. Sarcina has mainly been characterized as the causative agent of abomasal
bloat leading to the death of livestock [29]. There is still a debate whether Sarcina is pathogenic to
humans, although a number of cases of human disease, including gastric perforation, emphysematous
gastritis and gastric ulcer have been associated with Sarcina [28–30]. Our result demonstrates that the
hexane extracts of both P. guineense fruits and leaves contain antibacterial piperamide alkaloids, which
could be used as therapeutic agents in the treatment of Sarcina infections. The findings justify the
traditional use of P. guineense alcoholextracts for the treatment of stomach related problems, including
gastric ulcers.
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Table 4. HPLC-DAD and UHPLC/QTOF-MS data of alkaloids from a Piper guineense leaf hexane extract.












Mass [M + 1]
+ Other Ions m/z UVλ Absorption Max. Accuracy(ppm)
1. Unknown 11,840 2842 187,0306 * 165,0487 214, 236 -
2. Unknown (Ellagitannin?) 16,383 6173 312,1211 * 290,1392 210, 270 -
3. Unknown 23,461 6373 390,1516 * 368,1697 -
Unknown 33,389 12,567 231,0993 * 209,1174 220, 238, 320, 355 -
6. Unknown 36,456 13,267 187,0277 165,0458 143,068; 111,0420 -
7. Dihydropiperylin or piperlonguminine C16H19NO3 36,852 12,967 296,1250 * 273.1365 274.1431Q 2(M)+-23: 569,2628 210, 235, 284 −4,2212
7.1. Unknown 13,267 187,0277 165,0458 143,068; 111,0420 -
8. Piperylin C16H17NO3 38,563 13,567 294,1100 * 271,1208 272,1281Q 2(M)+-23: 565,2321 210, 240, 308, 344 −2,0740
9. Piperidine derivative 39,226 13,783 326,1374 * 304,1555 2(M)+23:629,2844 210, 234, 300
10. Dihydropiperlonguminine C16H21NO3 41.5 14,066 298,1337 * 298,1419 276,1518Q 210, 235, 300 27,50
10b. Piperine derivative 39,249 14,432 324,1211 * 302,1392 2(M)+-23: 625,2522 210, 235, 288
11. Unknown piperamide alkaloid 40,447 15,049 358,1528 * 336,1709 143,0682 210, 220, 246, 276, 355 -
11b. Unknown piperamide alkaloid 40,447 14,832 317,1330 * 295,1511 143,0644 210, 220, 246, 276, 355 -
12. Unknown 16,031 247,1612 225,1793 -
13. 4,5-dihydropiperine C17H21NO3 42,215 15,515 310,1417 * 287,1521 288,1598Q 210, 235, 287 −0,6771
15. Piperine C17H19NO3 44,809 16,647 308,1245 * 285,1365 286,1426Q 210, 240, 310, 342 −5,7119
16. Dihydrowisanine C18H23NO4 45,234 16,847 340,1530 * 317,1627 318,1711Q 210, 236, 306, 340 1,5581
17. Unknown 17,197 247,1659 225,1840 -
18. Wisanine C18H21NO4 48,433 17,846 338,1371 * 315,1471 316,1552Q 247,1662 218, 253, 304, 370, 372 0,8281
19. Unknown 18,795 243,1299 * 221,1480
UHPLC/QTOF-MS in positive ion mode was used, * = M + 23, Q = M + 1, ppm = mass accuracy in parts per million.All the results with an asterisk are [M + 23]+ results, they are adducts
with sodium (mass = 23 for sodium). Ions for compounds 5 and 14 in HPLC-DAD, Figure 1,were not detected in our UHPLC/QTOF MS system and thus these compounds are left away
from Table 4.
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method was used for estimating the MIC values, we found large variations in activity between the 
extracts demonstrating MIC values between 78 and 2500 μg/mL. From these results the ethanol 
extracts of the fruits and leaves stood out with very low MIC values of 78 μg/mL, thus 
demonstrating that ethanol could be a good solvent for extracting compounds active against P. 
mirabilis (Table 3). Contrary to our results, Okeke et al. [31], reported that P. guineense fruit extract is 
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the hexane leaf extract of Piper guineense. The compounds are numbered from Table 4.
2.1.5. Antibacterial Activity of P. guineense Extracts against Proteus Mirabilis
P. mirabilis was found to be rather resistant against most of the extracts of P. guineense. In the
primary screening, using agar diffusion, we found that the ethanol and methanol extracts were more
active than the chloroform fruit and leaf extracts (Table 1). However, when the microdilution method
was used for estima ing the MIC values, we found large variations in activity between the extracts
demonstrating MI values betwe n 78 and 2500 µg/mL. Fr m these res lts th ethanol ex racts of the
fruits and leaves stood out with very low MIC values of 78 µg/mL, thus demonstrating that ethanol
could be a good solvent for extracting compounds active against P. mirabilis (Table 3). Contrary to our
results, Okeke et al. [31], reported that P. guineense fruit extract is not active against Proteus mirabilis.
However, they found activity against Proteus vulgaris. We found that piperine showed significant
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activity against P. mirabilis with an inhibition zone of 16.0 mm and a MIC value of 78 µg/mL and
a MBC value of 156 µg/mL. Thus, piperine must be responsible for a part of the good antibacterial
activity of the ethanol extracts of the fruits and leaves against P. mirabilis, since piperine was observed
to be present in both extracts according to our preliminary HPLC-DAD data (Figure 1). In contrast to
piperine, we found that piperlongumine was not active against P. mirabilis. Thus, piperamide alkaloids
vary in respect to their antimicrobial activities, even though they would be closely related to their
molecular structures. Our results now demonstrate that especially ethanol extracts of P. guineense fruits
and leaves could be used for the treatment of urinary tract infections with Proteus mirabilis as the main
causative agent.
2.1.6. Antibacterial Activity of P. guineense Extracts against Enterobacter aerogenes
We found that a methanol extract of the fruit gave the largest zone of inhibition (49.7 mm) of all
tested extracts against E. aerogenes and the effect was comparable to tetracycline (45.3 mm) (Table 1).
Moreover, our MIC value for this extract, 39 µg/mL, correlated well with the large inhibition zone
(Table 3). The methanol leaf extract showed an inhibition zone of 29.3 mm and a large inhibition zone of
34.7 mm was also observed for the hexane-fruit extract, both extracts showing MIC values of 39 µg/mL.
The hexane leaf extract and ethanol fruit and leaf extracts showed promising inhibitory activity with
MIC values of 39 µg/mL and 78 µg/mL respectively. However, the size of the inhibition zone of the
hexane leaf extract, 17.8 mm, indicating just slight activity, did not correlate well with the low MIC of
78 µg/mL of this extract (Tables 1 and 3). This result might be due to the hydrophobic piperamide
alkaloids present in the leaf hexane extract not diffusing well into the agar and thus producing small
zones of inhibition. The chloroform fruit-extract was moderately active with a MIC value of 312 µg/mL.
To the best of our knowledge, this is the first report on the growth inhibitory activity of the extracts of
P. guineense against E. aerogenes. Moreover, we found that the piperamidespiperine and piperlongumine
were growth inhibitory against E. Aerogenes with inhibition zones of 18.7 mm and 12.7 mm, respectively,
MIC values of 39 µg/mL and 156 µg/mL, respectively and MBC values of 78 µg/mL and 312 µg/mL,
respectively. Thus, piperine which we have found to occur in all extracts, except from water extracts,
must be responsible for part of the activity of the methanol, ethanol and hexane extracts of the fruits and
leaves against Enterobacter aerogenes. Notably, the water extracts lacking piperamide alkaloids, were
devoid of activity. Enterobacter aerogenes is a Gram-negative pathogenic bacterium that is responsible
for most hospital-acquired infections [32]. It causes urinary tract infections, lower respiratory tract
infections, skin and soft tissue infections.
2.1.7. Antibacterial Activity of P. guineense Extracts against Escherichia coli
We recorded the lowest MIC of 156 µg/mL against E. coli for an ethanol extract of the leaves of
P. guineense, which correlated well with an inhibition zone of 19.8 mm (Tables 1 and 3). The methanol
fruit and leaf extracts of P. guineense also gave large inhibition zones of 20.7 mm and 20.3 mm,
respectively. The chloroform extracts of the fruits and leaves were also effective, both giving an
inhibition zone of 20.3 mm. Oppositely to the other extracts, the hexane and water extracts of
P. guineense were not active against E. coli. For the hexane extract, this result is contradictory since
this extract resembles the methanol and ethanol extracts to its piperamide alkaloid content. Therefore,
in the methanol and ethanol extracts of the leaves and fruits of P. guineense there must be some
compounds responsible for the activities which are not present in the hexane extracts. The result
further suggests that standardized P. guineense extracts could be used for possible alternative treatment
against pathogenic multidrug-resistant E. coli strains. This present study suggests that P. guineense
extracts could contain new antimicrobial agents for multidrug-resistant pathogens. Furthermore, we
found that the two piperamide pure compounds, piperine and piperlongumine, were effective against
E. coli with inhibition zones of 22.3 mm and 20.0 mm respectively and MIC values of 19 and 39 µg/mL,
respectively. This result could indicate that the antibacterial activity of P. guineense methanol and
ethanol extracts against E. coli is partly due to the mentioned piperamide alkaloids. Our results could
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justify the use of P. guineense ethanol extracts of the fruits and leaves for the treatment of diarrhoea in
African traditional medicine.
2.1.8. Antibacterial Activity of P. guineense Extracts against Salmonella enterica
The ethanol fruit extract of P. guineense showed the largest zone of inhibition of 21.7 mm for
S. enterica, and MIC and MBC values of 78 µg/mL and 156 µg/mL, respectively. The ethanol leaf
extract also showed a clear inhibition zone of 16.2 mm and a MIC of 78 µg/mL (Tables 1 and 3). These
results are in accordance with a previous investigation which demonstrates that ethanol extracts of
P. guineense are growth inhibitory against S. enterica serovar enteritis [33]. However, oppositely to our
results, Temitope [33], also found that water extracts of P. guineense inhibit the growth of S. enterica.
These differences might be due to Temitope [33] using a different serovar of S. enterica. The result
specifically demonstrates that, the more polar ethanol extracts contain antibacterial compounds that
effectively inhibited the growth of this bacterium. Moreover, we found that in addition to the ethanol
extracts also chloroform, hexane and methanol extracts gave some growth inhibition against S. enterica,
with inhibition zones up to 18.0 mm. Piperine and piperlongumine showed clear inhibition zones of
14.7 and 11.3 mm with MIC values of 78 µg/mL and 625 µg/mL.
2.2. UHPLC/QTOF-MS Results
HPLC-DAD and UHPLC/Q-TOF MS were used for phytochemical profiling of antibacterial
extracts of P. guineense and for the identification of piperamide alkaloids in Piper guineense. Our
HPLC-DAD data indicates that piperamide alkaloids are the predominant compounds in P. guineense
hexane, methanol, ethanol and chloroform extracts (Figure 1) and these compounds are suggested to
be responsible for the antibacterial effects we have observed for this plant in agreement with other
authors [7,34]. For proper identification and characterization of the piperamide alkaloids, a hexane
extract of the leaf was chosen. This is because the chromatographic peaks in the hexane extract were
more clearly visible and better resolved when compared with the chloroform, methanol and ethanol
extracts and moreover, the HPLC-DAD profile of the hexane extract was still found to be very similar
to those of the other extracts. In addition, the hexane leaf extract was chosen for phytochemical
analysis since we observed large inhibition zones for this extract against most of the bacterial strains,
as well as the lowest MIC result of 19 µg/mL against Sarcina sp. Our UHPLC/QTOF-MS result of a
leaf hexane extract of P. guineense is presented in Table 4. Altogether 18 compounds were identified,
of which the majority were piperamide alkaloids. Among these compounds, the previously known
piperamidealkaloids piperine, dihydropiperine, piperylin, dihydropiperylin or piperlonguminine,
dihydro-piperlonguminine, wisanine, dihydrowisanine and various derivatives of piperine were
identified. These derivatives of piperidinewere identified for the first time in this plant extract
(compounds 9, 10b, 11 and 11b in Table 4). The mass spectrometric data of these compounds were
compared to the literature on piperamide alkaloids in Piper species [15,35,36].
In our UHPLC/QTOF-MS runs, positive ion mode was used to get the [M + Na]+ or [M + H]+
ions of the expected piperamide alkaloids. Papers on piperamide alkaloids which have been found
from Piper spp. were used as references [15,16,35]. Among the piperamide alkaloids we have found
in the leaves of P. guineense, the following could be identified and some of them in high quantities.
The exact calculated mass of dihydropiperylin or piperlonguminine (7), Rt UHPLC12.967 min, was
deduced to be 273.13648 according to the molecular formula of C16H19NO3. The [M + Na]+ ion for
dihydropiperylin was 296.1250 and that of piperylin (8) at tR UHPLC 13.567 min was found to be
294.110. Both compounds were present also in the fruit extracts of P. guineense. Moreover, piperine (15)
at tR 44.809 min (HPLC-DAD), showing a [M + Na]+ ion at m/z 308.1245 and dihydropiperine (13)
at tR 42.215 min (HPLC-DAD), with a [M + Na]+ ion at m/z 310.1417 were present in the leaf extract.
To confirm the identity of compound 15 to be piperine, we compared the UVλ max-spectrum and
the retention time of this compound to a commercial piperine reference compound and the data was
found to match. Piperine has been previously reported to be present in in P. guineense extracts of the
Antibiotics 2018, 7, 98 11 of 18
fruits [16]. Wisanine (18) at tR 48.429 min with a [M + Na]+ ion at m/z 338.1371 and dihydrowisanine
(16) at tR 44.848 min with a [M + Na]+ ion at m/z 340.1530 were also found to be present in the hexane
leaf extract. Moreover, some derivatives of piperidine (compounds 9, 10b, 11 and 11b in Table 4) were
identified for the first time in this plant extract. Wisanine and dihydrowisanine were present also in
the chloroform, ethanol, methanol and hexane extracts according to our HPLC-DAD results. The other
alkaloids found in the extracts include: Dihydropiperlonguminine (10) (tR 39.226 min, [M + Na]+ ion
at m/z 298.1337); a piperine derivative composed of piperine + 1 oxygen- one double bond (10b) (tR
39.249 min, [M + Na]+ ion at m/z 324.1211); an unknown piperamide alkaloid (11) (tR 40.447 min,
[M + Na]+ ion at m/z 358.1528); and a dihydro derivative of piperidine (9) (tR 39,226 min, [M + Na]+
ion at m/z 326.1374) (Table 4).
3. Discussion
In this study, Piper guineense fruit and leaf extracts and piperamide alkaloid compounds have
revealed potent antibacterial activity against Gram-positive and Gram-negative bacteria. P. guineense is
used by traditional healers in West Africa for various medicinal purposes and often, as herbal remedies
for the treatment of symptoms related to bacterial infections, such as diarrhoea, cough and rashes as
well as for the treatment of infected wounds and thus these uses are now justified by our results.
In our study, we used Pseudomonas aeruginosa as a Gram-negative model bacterium, since it is
capable of causing life-threatening nosocomial infections and many combination therapy resistant
strains have been reported [37,38]. In recent times, because of the increase in microbial resistance,
only few antibiotics are effective in the treatment of the multidrug-resistant (MDR) and extensively
drug-resistant (XDR) lineages of Pseudomonas aeruginosa infections [39]. Our results reveal potent
growth inhibitory effects of both leaf and fruit chloroform extracts of P. guineense against P. aeruginosa,
both giving MIC values of 78 µg/mL against this bacterium. This result agrees with Eruteya et al. [26],
who also reported that extracts of P. guineense fruits give good growth inhibitory activity against
P. aeruginosa.
Staphylococcus aureus is becoming increasingly resistant to conventional drug therapies, with
MRSA and VRSA strains which are not responding well to any drugs [5]. Previous research has
shown that plant-derived compounds and plant extracts could be used as novel treatments and
sources of new antibacterial compounds against multi-drug-resistant (MDR) pathogens, including
methicillin-resistant Staphylococcus aureus (MRSA) [5]. Our results indicate that alcohol extracts as well
as chloroform and n-hexane extracts from the fruits and leaves of P. guineense could be used as good
sources for piperamide alkaloids which could be used for treatment of infections caused by S. aureus.
Interestingly, we found that the extracts were as growth inhibitory as the pure compounds, piperine
and piperlonguminine. This suggests that some of the other alkaloids in the extracts could be even
more powerful and warrants for further isolation of piperamide alkaloids from P. guineense to test their
effects against S. aureus.
E. coli is a Gram-negative bacterium that is capable of causing infectious diarrhoea in humans [40].
We found that methanol, ethanol and n-hexane extracts of P. guineense were active against this
bacterium. Thus, we recommend that alcohol extracts of P. guineense leaves and fruits could be used for
the treatment of E. coli infections. Our promising resultson the inhibitory capacity of especially ethanol
extracts of the fruits of P. guineense against E. coli would prompt to study the effects of alcohol extracts
also against strains of E. coli. Extracts of various polarities, such as methanol, ethanol, chloroform,
hexane, cold water macerations and hot water decoctions of the fruits and leaves were screened for
antibacterial activity.
We found that piperine and piperlongumine commercial compounds were active against most
of the bacteria investigated in our study, with piperlongumine showing the lowest MIC value of
9.7 µg/mL against Sarcina sp. Piperine and piperlongumine showed significant activity against E. coli
with MIC values of 19 µg/mL and 39 µg/mL, respectively. Piperine has been previously reported
to give significant antibacterial activity against some bacterial strains [24,25]. Piperine isolated from
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the fruits of black pepper (Piper nigrum) was found to be effective against Pseudomonas aeruginosa and
gave a MIC of 250 µg/mL against this bacterium [41] and this result is in accordance with our MIC
of 156 µg/mL. At low concentrations of 0.1–10 µg/mL, piperine was found to reduce swarming and
swimming motility of E. coli [42]. Moreover, piperine was found to be active against S. aureus with a
MIC of 250 µg/mL and reduced the MIC of mupirocin fourfold and of ciprofloxacin eightfold [43], [44]
and was found to inhibit efflux pumps in S. aureus [43].
In our screenings we found that the cold water macerations and hot water decoctions of the
fruits and leaves did not show any inhibitory activity against most of the bacteria used for the study.
The reason for water extracts lacking antibacterial activity could be attributed to the fact that the
bioactive compounds present in the other extracts, which are mostly piperamide alkaloids, are not
soluble in water and not even in boiling water according to our HPLC-DAD fingerprints of water
extracts. However, in contradiction to our results, there are some reports on the antibacterial effects of
water extracts of Piperguineense against Salmonella enterica [33]. The growth inhibitory activity of the
water extract in this report might be attributed to the high concentrations used (20–60 mg/mL) and to
some other compounds than piperamide alkaloids, such as phenolic acids. Thus, when P. guineense
extracts are to be used for the treatment of bacterial infections in traditional medicine, our result now
recommend that oily or ethanol preparations should be used. Our results on the chloroform extracts of
P. guineense possessing the largest activity against P. aeruginosa differs from previous studies stating
that methanol extracts of P. guineense are usually the most active ones against this bacterium [26].
From our UHPLC/QTOF-MS analysis conducted on the P. guineense extracts, it could be seen that
the extracts were rich in alkaloids and thus their antibacterial activities could be mostly attributed
to the presence of numerous piperamides (Table 4, Figure 1). The chemical structures of some of the
piperamide compounds identified in this study are shown in Figure 2. Of the piperamides we have
found in a hexane leaf extract of P. guineense, wisanine, dihydrowisanine, piperine, piperlongumine,
4,5-dihydropiperlonguminine and 4,5-dihydropiperylin have been earlier identified in Piper guineense
fruits [15,16,35]. In addition to these piperamides we found some new structures, such as a piperine
and a piperidine alkaloid derivative (compounds 9 and 10b in Table 4) and two unknown piperamide
alkaloids (compounds 11 and 11b in Table 4). To the best of our knowledge to date there are no
piperamides reported in the literature with the same UVλ maxima and masses.
4. Materials and Methods
4.1. Plant Material Collection
The fruits and leaves of P. guineense used in this study were collected from a rural village in
Imo State, South Eastern Nigeria. The plant materials were authenticated at the Department of Crop
Science of the Federal University of Technology, Owerri, Nigeria. Voucher specimens are deposited in
the herbarium of the Department of Crop Science of the same university with the specimen number
FUTO/SAAT/NS/005A for the fruit and FUTO/SAAT/NS/005B for the leaf. The reference flora used
to identify the species is “Useful Plants of West Tropical Africa.” The species commonly occur in South
Eastern Nigeria and the geographical coordinates of occurrence of the tested species is 5◦45′00” N,
8◦30′00” E.
4.2. Extraction
The air dried plant materials were milled with a grinder to obtain finely ground powdery samples.
Sequential extraction was carried out using solvents of varying polarities, starting with the least polar
solvent. First, 40 g of the plant material was extracted with 300 mL of hexane, followed by extraction
with 300 mL of chloroform, then 300 mL of ethanol and the residue was finally extracted and washed
with 300 mL of methanol. Seed and leaf plant materials were used for the extractions. For each of the
solvents used, the extraction was conducted in duplicates and each extract was filtered using filter
paper (Whatman GE Healthcare, Chicago, IL, USA) into a flask of known weight. The filtrate was
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evaporated using a Rotavapor (Heidolph VV2000) combined with a water bath not exceeding +40 ◦C,
thereafter the extracts were lyophilized for two days to dry completely. The extraction yield for the
extractsare as follows: hexane fruit extract (5.3%), hexane leaf extract (1.4%), chloroform fruit extract
(8.9%), chloroform leaf extract (4.7%), ethanol fruit extract (8.5%), ethanol leaf extract (5.0%), methanol
fruit extract (10.5%) and methanol leaf extract (6.0%). Macerations and hot water decoctions were also
prepared from the plant samples since these preparations are used in traditional medicine. Macerations
were prepared by weighing 10 g of the fruit and leaf plant materials into Erlenmeyer flasks. 100 mL of
water was added and extraction was performed for 24 h using a magnetic stirrer. The mixture was
centrifuged at 2000 rpm for 15 min (Eppendorf AG centrifuge 5810R, Germany). For the decoctions,
10 g of the plant material was boiled with 100 mL of water and allowed to cool. The mixture was
centrifuged for 15 min at 2000 rpm (Eppendorf AG centrifuge 5810R, Hamburg, Germany). Both the
macerations and decoctions were carefully filtered using filter paper (Schleicher & Schuell, ∅ = 150
mm, Hamburg, Germany) and freeze dried for two days in a lyophilizer. The extraction yields are
as follows: decoction of the seed (2.8%), decoction of the leaf extract (2.4%), maceration of the seed
(3.0%) and maceration of the leaf (2.8%). Prior to the agar diffusion test, the freeze dried extracts were
reconstituted and re-dissolved in their corresponding solvents or in MeOH to a final concentration of
50 mg/mL for the antibacterial screening according to the method of Anyanwu and Nwosu [45] and
Salih et al. [46].
4.3. Methods of Analytical Chemistry
4.3.1. HPLC-UV/DAD Method
The liquid chromatographic system consisted of aHPLC Waters 600 E pump and a controller
coupled to a 991 photodiode array detector. Samples were injected using an autosampler controlled by
Agilent Chemstation software (Waters Corp., Milford, TX, USA). A HypersilRp C18 column was used
for the separations (length: 60 mm; internal diameter: 2 mm). 5–20 µL of the extracts (5–10 mg/mL in
100% MeOH) were injected. Gradient runs were performed using two solvent systems: A (aqueous
1.5% tetrahydrofuran + 0.25% orthophosphoric acid) and B (100% MeOH). Flow rate was 2 mL/min.
UV fingerprint chromatograms were constructed at 220, 270, 280, 320 and 360 nm. UVλ absorption
maxima spectra of the major compounds in the P. guineense extract were recorded between 200
and 400 nm using Agilent Chemstation software. The compounds in the extracts were identified
by comparing their retention times and UVλ absorption maxima spectra with those of commercial
reference standards (piperine and piperlongumine) and previous literatureon HPLC-DAD data for
piperamide alkaloids was also used [15,16].
4.3.2. UHPLC/Q-TOF MS Method
The masses of piperamide alkaloids in a leaf hexane extract were identified using UHPLC-DAD
(Model 1200 Agilent Technologies)-JETSTREAM/QTOFMS (Model 6340 Agilent Technologies)
equipped with a 2.1 × 60 mm, 1.7 µm C18 column (Agilent technologies) according to
Taulavuori et al. [47]. The gradient range was from 0–50% of solvent A (aqueous 1.5% tetrahydrofuran
+ 0.25% acetic acid) and solvent B (100% methanol) and flow rate 0.4 mL/min. The qt of mass spectra
were acquired at positive ion mode and mass rangefrom 100–2000 m/z was used.
4.4. Bacterial Strains
The bacterial strains used in this investigation were obtained from the Division of Pharmaceutical
Biosciences, Faculty of Pharmacy, University of Helsinki, Finland. In all, the growth inhibitory activity
of the extracts were investigated using the Gram-positive strains Sarcina sp. FOMK (Division of
Pharmaceutical Biosciences, University of Helsinki), Staphylococcus aureus ATCC 25923 and Bacillus
cereus ATCC 10987 and the Gram-negative strains Proteus mirabilis 43071, Enterobacter aerogenes
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ATCC13048, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853 and Salmonella enterica
ATCC 43845).
4.4.1. Antibiotics and Pure Compounds
Tetracycline hydrochloride (Sigma-Aldrich, St. Louis, MO, USA) and rifampicin (Sigma-Aldrich,
St. Louis, MO, USA), were used as standard antibiotics for the investigation. Analytical
grade piperine and piperlongumine standards (≥97.0% purity) purchased from TCI Europe N.V.
(Zwijndrecht, Belgium) were used as standard compounds.
4.4.2. Agar Disk Diffusion Method
Gram-positive and Gram-negative bacteria representing potential human pathogenic bacteria
were used to investigate the in vitro growth inhibitory effects of P. guineense extracts. A total of
twelve fractions from the fruit and leaf extracts of this plant were tested against eight bacterial strains.
An agar disk diffusion method was applied for the initial screening [46]. The freeze dried extracts
were re-dissolved in those solvents used originally for their extraction according to the method of
Anyanwu and Nwosu [45]. Each of the extracts were prepared to a final concentration of 50 mg/mL
(stock solution). Tetracycline and rifampicin were used as positive controls for the bacterial strains.
The antibiotics were dissolved in methanol to a final concentration of 10 mg/mL used for the test.
Sterile petri dishes (∅ =1 4 cm, VWR Finland) were used for the screenings. For the antibacterial
screening, twenty-five mL of sterile base agar (Antibiotic agar No. 2, Difco, VWR Finland) was applied
as a bottom layer into the sterile petri dishes using a sterile, serological pipet (Falcon, Becton Labware
Europe) and allowed to solidify. Thereafter twenty-five mL of isosensitest agar (OXOID, Thermo
Fisher Scientific) was applied as the top layer. The petri dishes were all allowed to solidify and then
stored at +4 ◦C. The screening started with inoculation of the bacteria onto solid nutrient agar slants
which were incubated overnight at +37 ◦C. The viable bacterial cultures from the agar slants were used
to prepare an inoculum for the test. Bacteria from the agar slants were transferred into 2 mL of 0.9%
(w/v) sodium chloride (NaCl) solution in a sterile glass tube using a sterile inoculation loop. 1 mL
of the suspension was transferred into another sterile glass tube and the absorbance was measured
at 625 nm (UV–Visible Spectrophotometer, Pharmacia LKB-Biochrom 4060). The other 1 mL of the
suspension (sterile part) was diluted with the 0.9% NaCl solution so that the absorbance at λ = 625 nm
becomes 0.1 (this suspension contains approximately 1.5 × 108 CFU/mL). 200 µL of this diluted
bacterial suspension was spread evenly on each petri dish and left to dry for some seconds with the lid
open. A sterile cork borer (11 mm in diameter) was used to make six holes equidistantly from each
other on the agar surface of the petri dishes. 200 µL of the 50 mg/mL plant extracts and 200 µL of
the 10 m/mL antibiotics were carefully pipette into the holes respectively. Methanol, ethanol, hexane
and chloroform, 200 µL of each, were used as solvent controls respectively. The petri dishes were
transferred to the cold room and incubated at +4 ◦C for 1 h, thereafter they were incubated overnight
at +37 ◦C. The diameters of the zones of inhibition were measured with a calliper under a petri dish
magnifier and expressed as the mean of the diameters of three replicates ± SEM.
The Activity index (AI) of the various extracts was measured in relation to the standard antibiotic
tetracycline according to Fyhrquist et al. [48].
Thus, AI = Inhibition zone of the plant extract/Inhibition zone of standard antibiotic
4.4.3. Microdilution Method for MIC and MBC Estimation
From the result obtained from the agar disk diffusion assay, minimum inhibitory concentration
(MIC) was estimated for some selected extracts based on their good antibacterial activity. MIC is
considered to be the lowest concentration of an extract or compound resulting in the inhibition of
at least 90% of the growth of a bacterial strain. MIC values were determined using a microdilution
turbidimetric broth method based on the guidelines of Clinical and Laboratory Standards Institute [49].
Only extracts which expressed remarkable antibacterial activity in the agar plate method were tested
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for MIC. For the MIC evaluation, two-fold serial dilutions of the extracts from 2500–9.75 µg/mL
were prepared in sterile Mueller-Hinton broth. Commercial pure compounds, piperine (1 mg/mL
concentration in methanol) and piperlongumine (1 mg/mL concentration in methanol) were also
two-fold serially diluted in Mueller -Hinton broth. Tetracycline and rifampicin were each two-fold
serially diluted in Mueller-Hinton broth from 125–0.48 µg/mL respectively. 96 well microtiter plates
(Nunc, Nunclone, Denmark) were used for the tests. The bacterial cultures were inoculated on
Mueller-Hinton agar slants or in 5 mL Mueller-Hinton broth and grown for 24 h at +37 ◦C before
the test. The turbidity of 1 mL of the overnight bacterial culture was measured at 625 nm using a
UV–Visible Spectrophotometer type 1510 (Thermo Fisher Scientific Oy). The absorbance was adjusted
to 0.1 at 625 nm (approximately 1.0 × 108 CFU/mL). 100µL of this suspension A625 = 0.1 was further
diluted 100-fold to get a working suspension or inoculum containing approximately 1.0× 106 CFU/mL.
100 µL of this inoculum and 100 µL of the plant extracts, pure compounds, antibiotics and solvent
controls, were introduced into the 96 well microtiter plates. Therefore, each well contained 5 × 105
CFU/mL. The solvent controls contained a maximum of 5% (v/v) of each solvent to be tested for
toxicity. The growth control (GC wells) contained only the bacterial suspension and the test wells
(T wells) contained plant extracts or pure compounds + bacterial suspension. Moreover, negative
control wells were prepared for each plant extract/compound to be tested and these wells contained
plant extract/pure compound and the broth only in order to subtract the light absorbance of extracts
and compounds from the wells containing the corresponding extracts/compounds with bacteria.
The microwell plates were incubated for 24 h in an incubator coupled to a shaker at +37 ◦C. The
turbidity of the wells at 620 nm was recorded using a Victor 1420 spectrophotometer (Wallac, Finland).
The MIC values were considered as the lowest concentration of each tested extract/compound or
antibiotic which resulted in a 90% or more inhibition of the growth control. The tests were done in
triplicate and the % growth was expressed as the mean of these triplicates ± standard error of mean
(SEM). The minimum bactericidal concentration (MBC) was evaluated by pipetting 100 µL from those
wells of the microtiter plate, which contained 2 and 4 times higher concentrations than the MIC values
on petri dishes (∅ = 9 cm) containing Mueller-Hinton agar, where after, the dishes were incubated for
24 h at +37 ◦C. The MBC was taken as the lowest concentration where no visible growth on the petri
dish was observed after the incubation.
5. Conclusions
The present study demonstrated that extracts of P. guineense, enriched in alkaloids, have potent
antibacterial activity against a panel of Gram-positive and Gram-negative bacteria, including significant
human pathogens. It has been established through this study that alkaloids are the main antibacterial
compounds present in P. guineense leaves and fruits. However, water extracts and decoctions, which
are frequently used as traditional medicinal preparations, were devoid of these alkaloids even at
the highest tested concentration of 50 mg/mL and thus inactive against the studied bacteria. Our
results revealed that P. guineense alcohol, chloroform and hexane extracts from the leaves and fruits are
richsources of piperamide compounds which could help to combat bacterial infections. Thus our results
encourage especially the use of alcohol extracts of P. guineense leaves and fruits in traditional medicine.
Our results warrant further in depth research on the antibacterial mechanisms of action of
piperamide compounds, since this is not thoroughly studied. Plant derived compounds with new
mechanisms of action could be used for the treatment of multi-drug resistant bacteria and P. guineense
as well as other species of Piper could be sources for some of these compounds. Moreover, the
alkaloids in P. guineense could be investigated for their anti-biofilm activities, including quorum
sensing. The inhibitory activity observed with the various fractions and extracts against the tested
bacteria in this investigation, warrants further exploration of the bioactive compounds from P. guineense
as molecular scaffolds for new therapeutic agents in modern antimicrobial therapy, as well as on their
potential as adjuvants together with conventional antibiotics to restore or to increase the effects of the
antibiotics in current use. The possibility to use piperamide alkaloids from P. guineense (and other
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Piper spp.) for the treatment of drug resistant strains of Pseudomonas aeruginosa, Staphylococcus aureus,
Bacillus cereus and Salmonella enterica should be explored.
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